Home
/
NowPatient Blog
/
What is Glucagon-like peptide-1 (GLP-1)?

What is Glucagon-like peptide-1 (GLP-1)?

Navin Khosla NowPatientGreen tick
Created on 9 Jun 2024
Updated on 16 Jul 2024

Glucagon-like Peptide-1 (GLP-1) is a hormonal agent that not only regulates blood sugar levels by causing the release of insulin , but also has an impact on body weight by reducing apetite, making it a unique and important medication for the treatment of type 2 diabetes and obesity. Here, we will take a closer look at GLP-1 and its mechanism of action and therapeutic uses.

Understanding GLP-1

Glucagon-like peptide-1 (GLP-1) is central to the metabolism of glucose in the body. It originates from the proglucagon peptide and is mainly released by the intestinal L-cells after meals. It contains 30 or 31 amino acids and helps to regulate glucose concentrations in the body, as well as having an effect on the release of insulin, gastric emptying, and your appetite.

What is GLP-1?

Alongside glucose-dependent insulinotropic peptide (GIP), GLP-1 is an incretin hormone that enhances insulin secretion in a glucose-dependent manner. This action reduces blood glucose levels after meals. GLP-1 also helps prevent glucagon secretion, which would otherwise increase blood glucose levels, and slows gastric emptying, which helps to manage postprandial glucose levels. Glucagon-like peptide-1 receptor agonists gained FDA approval to treat diabetes and obesity in the 2000s.

Endogenous GLP-1 is broken down rapidly by dipeptidyl peptidase-4 (DPP-4), thus giving it a half-life of a few minutes. To overcome this, GLP-1 receptor agonists and DPP-4 inhibitors have been developed to increase GLP-1 activity.

Biological functions of GLP-1

GLP-1 and insulin secretion

GLP-1 affects the metabolism of glucose by stimulating the secretion of insulin in a glucose-dependent manner and preventing the release of glucagon.

This dual action helps to maintain optimal blood glucose levels, especially after meals. GLP-1 also increases the number of beta-cells and inhibits cell death, which in combination improves beta-cell survival and function.

Effects on appetite and food Intake

GLP-1 also affects appetite and food intake, which together has a significant impact on weight management. GLP-1’s delay gastric emptying which contributes to a prolonged feeling of fullness and therefore a delay in food ingestion. GLP-1 receptors in the brain also help regulate appetite, further enhancing its role in weight loss.

Cardiovascular and neuroprotective roles

GLP-1 also has significant cardiovascular and neuroprotective effects. It supports heart function by promoting myocardial glucose uptake and utilization, the reduction of oxidative stress, and the inhibition of apoptosis in cardiomyocytes.

GLP-1 also promotes vasodilation (relaxation of blood vessels) by stimulating the production of nitric oxide. This improves blood flow. GLP-1 also reduces inflammation and stimulates nerve growth, offering benefits for the treatment of neurodegenerative conditions.

Therapeutic uses of GLP-1

GLP-1 in diabetes treatment

GLP-1 receptor agonists by providing effective glycemic control and cardiovascular benefits have transformed the management of Type 2 Diabetes. They not only reduce blood glucose levels, but also enhance the secretion of insulin in a glucose-dependent manner, significantly impacting the overall management of diabetes. Medications such as tirzepatide and semaglutide have been shown to achieve weight management goals more effectively in patients than traditional treatments such as metformin or sulfonylureas.

GLP-1 and obesity management

The role of GLP-1 in the management of obesity is significant. GLP-1 analogs such as dulaglutide, liraglutide are approved in the U.S. and Europe alongside a reduced-calorie diet and increased physical activity. Clinical studies have shown that GLP-1 receptor agonists cause significant weight loss, from 6.0 to 8.8 kg, by creating a feeling of fullness and reducing appetite.

Other potential applications

GLP-1 receptor agonists beyond diabetes and weight management, are also being explored for their potential in the treatment of other health issues such as fatty liver and cardiovascular diseases. The inhibition of certain enzymes involved in the production of cholesterol by GLPs suggests a cardioprotective role, with the potential to reduce the formation of plaque. GLP’s are also being studied for their effects on cognitive impairment and neurological problems, and their ability to offer a broader range of therapeutic applications.

Mechanisms of GLP-1 action

Mechanism of action in glucose regulation

GLP-1 is secreted by L cells in the gastrointestinal tract in response to meals, initiating a series of effects that regulate blood glucose levels. The hormone enhances insulin secretion and inhibits the release of glucagon by binding to GLP-1 receptors on pancreatic cells. GLP-1 also influences the metabolism of glucose by delaying gastric emptying and reducing the production of hepatic glucose to moderate postprandial glucose spikes.

Impact on central nervous system

The brain contains GLP-1 receptors, particularly in areas involved in appetite and glucose regulation. GLP crosses the blood-brain barrier, acting on these receptors to modulate appetite and satiety. This is vital for its role in reducing food intake and influencing reward-related behaviors that contribute to its effects on weight management.

Influences on gastrointestinal motility

GLP-1 slows gastrointestinal motility and inhibits postprandial acid secretion, contributing to a reduced rate of nutrient absorption. This action not only affects glucose levels but also aids in weight management by extending periods of satiety and reducing overall caloric intake.

What are the side effects of GLP-1 agonists?

The most common side effects of GLP-1 agonists include:

  • Loss of appetite
  • Nausea
  • Vomiting
  • Diarrhea

Other side effects can include:

  • Dizziness
  • Increased heart rate
  • Infections
  • Headaches
  • Indigestion

Severe, but rare side effects include:

  • Pancreatitis (inflammation of the pancreas)
  • Medullary thyroid cancer
  • Acute kidney injury
  • Worsening diabetes-related retinopathy

What are the risks or complications of GLP-1 agonists?

Risks include:

  • Allergic reactions
  • Use during pregnancy
  • Low blood sugar (hypoglycemia)

GLP-1 agonists and allergic reactions

Some people form antibodies to GLP-1 agonists, particularly with exenatide, causing issues with the effectiveness of the medication. It can also cause allergic reactions at the injection site or potentially anaphylaxis.

Conclusion

We’ve delved into the role of GLPs in metabolism, their impact on blood sugar regulation, appetite control, and weight management. Not only have we discussed its biological functions and mechanisms, but also its therapeutic uses in treating conditions like type 2 diabetes and obesity. Harnessing GLP-1s, gives us the potential to significantly advance treatment approaches and enhance diabetic patient outcomes in the management of diabetes and obesity.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

What role does GLP-1 play in weight management?

GLP-1 medications help to reduce appetite by slowing down the movement of food from the stomach to the small intestine, making you feel fuller for a longer, potentially leading to a decrease in food intake and aiding in weight loss.

 

How does semaglutide relate to GLP-1 and medications like Ozempic?

Semaglutide acts as a GLP-1 receptor agonist and is the key ingredient in medications such as Ozempic, Wegovy, and Rybelsus. The main difference between these medications lies in their method of administration: Ozempic and Wegovy are subcutaneous injections, whereas Rybelsus is taken orally.

 

What are the medical uses of GLP-1 peptides?

GLP-1 agonists are primarily used for the management of type 2 diabetes mellitus and obesity. They belong to a larger category of medications aimed at treating these conditions by influencing the body’s endocrine responses.

 

Is it possible to purchase GLP-1 medications without a prescription?

No. GLP-1 medications require a prescription and should only be used under the guidance of a healthcare provider due to the potential for side effects. They are not available over the counter.

Now Patient Data Security

Data Security

Trusted and certified to keep your data safe.

Learn moreNow Patient Data SecurityNow Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient dashboard

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers